D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$701M |
| 2 |
Booking.com
BKNG
|
+$503M |
| 3 |
Alibaba
BABA
|
+$443M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$389M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$267M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.03B |
| 2 |
Amazon
AMZN
|
+$463M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$436M |
| 4 |
Salesforce
CRM
|
+$387M |
| 5 |
Moderna
MRNA
|
+$354M |
Sector Composition
| 1 | Technology | 20.28% |
| 2 | Consumer Discretionary | 13.97% |
| 3 | Healthcare | 10.06% |
| 4 | Financials | 9.79% |
| 5 | Communication Services | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BFS
2951
Saul Centers
BFS
$789M
| $279K | ﹤0.01% |
6,343
-2,439
| -28% | -$107K |
|
2952
Esperion Therapeutics
ESPR
$554M
| $278K | ﹤0.01% |
+23,079
| New | +$278K |
|
2953
Grocery Outlet
GO
$1.66B
| $278K | ﹤0.01% |
+12,893
| New | +$278K |
|
|
SEEL
2954
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $276K | ﹤0.01% |
30
+6
| +25% | +$55.2K |
|
2955
Noodles & Co
NDLS
$31.1M
| $275K | ﹤0.01% |
23,330
-41,425
| -64% | -$488K |
|
2956
TFS Financial
TFSL
$3.74B
| $275K | ﹤0.01% |
+14,453
| New | +$275K |
|
2957
Nuvalent
NUVL
$5.84B
| $274K | ﹤0.01% |
+12,142
| New | +$274K |
|
2958
SELLAS Life Sciences
SLS
$170M
| $274K | ﹤0.01% |
29,921
-2,193
| -7% | -$20.1K |
|
2959
SelectQuote
SLQT
$356M
| $273K | ﹤0.01% |
+21,112
| New | +$273K |
|
|
AAT
2960
American Assets Trust
AAT
$1.28B
| $272K | ﹤0.01% |
+7,280
| New | +$272K |
|
2961
Acumen Pharmaceuticals
ABOS
$80M
| $272K | ﹤0.01% |
+18,314
| New | +$272K |
|
|
ARGO
2962
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $272K | ﹤0.01% |
5,208
+115
| +2% | +$6.01K |
|
2963
Enpro
NPO
$4.75B
| $271K | ﹤0.01% |
3,105
| – | – |
|
2964
CRH
CRH
$75.5B
| $270K | ﹤0.01% |
5,769
-20,869
| -78% | -$977K |
|
2965
Mercury Insurance
MCY
$4.39B
| $270K | ﹤0.01% |
4,855
-15,150
| -76% | -$843K |
|
|
PRTK
2966
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $270K | ﹤0.01% |
55,507
-51,401
| -48% | -$250K |
|
2967
Orion Group Holdings
ORN
$323M
| $268K | ﹤0.01% |
49,263
-37,255
| -43% | -$203K |
|
2968
Royal Caribbean
RCL
$88.5B
| $268K | ﹤0.01% |
3,009
-293,785
| -99% | -$26.2M |
|
|
WW
2969
DELISTED
WW International
WW
| $268K | ﹤0.01% |
14,677
+8,443
| +135% | +$154K |
|
|
CLYM
2970
Climb Bio, Inc. Common Stock
CLYM
$152M
| $268K | ﹤0.01% |
+14,912
| New | +$268K |
|
2971
Victory Capital Holdings
VCTR
$4.59B
| $267K | ﹤0.01% |
7,625
-18,664
| -71% | -$654K |
|
2972
Ducommun
DCO
$1.43B
| $266K | ﹤0.01% |
5,282
+1,096
| +26% | +$55.2K |
|
2973
Comfort Systems
FIX
$28.2B
| $266K | ﹤0.01% |
3,728
-387
| -9% | -$27.6K |
|
2974
John B. Sanfilippo & Son
JBSS
$752M
| $266K | ﹤0.01% |
3,253
| – | – |
|
2975
Bassett Furniture
BSET
$141M
| $265K | ﹤0.01% |
+14,653
| New | +$265K |
|